Spry Pharmaceuticals
- Categories:Industrialization
- Time of issue:2022-12-30 00:00:00
- Views:0
Description:
Information
Hefei Sipurui Pharmaceutical Co., Ltd. is a holding subsidiary invested and established by Hefei Huafang Pharmaceutical Technology Co., Ltd. The company was established in June 2019 with a registered capital of 20 million yuan and is located in the Baiyan Science and Technology Park of Hefei National High tech Development Zone. The company is committed to the small-scale production and pilot scale test platform of high-end preparations, mainly producing venlafaxine hydrochloride sustained-release tablets, nifedipine controlled-release tablets, etc.
Scan the QR code to read on your phone
Mobile